NFL group, company teaming up for brain drug test
A potential treatment for traumatic brain injuries may be tested
in retired professional football players, who are the focus of
concern over blows to the head.
Neuralstem, Inc., of Rockville, Md., said Wednesday it is
working with the National Football League Alumni Association to
study the feasibility of such a test, which would need government
approval. It would involve a drug that’s now in an early human
trial for treating depression. In animal studies, the drug appeared
to stimulate creation of brain cells.
Concern has mounted about brain injuries and disease in former
NFL players, driven in part by some high-profile suicides.
Thousands of former players are suing the league and its teams,
saying that for years the NFL did not do enough to protect players